Current strategies for subunit and genetic viral veterinary vaccine development.
about
Plant-produced viral bovine vaccines: what happened during the last 10 years?A cucumber mosaic virus based expression system for the production of porcine circovirus specific vaccines.Bacterial ghosts as adjuvants: mechanisms and potential.Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus.Self-assembly and release of peste des petits ruminants virus-like particles in an insect cell-baculovirus system and their immunogenicity in mice and goats.DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.Induction of antibody and interferon-γ production in mice immunized with virus-like particles of swine hepatitis E virusStructural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.Targeted Collection of Plasmid DNA in Large and Growing Animal Muscles 6 Weeks after DNA Vaccination with and without Electroporation.HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in miceFormulation and delivery of vaccines: Ongoing challenges for animal management.Delivery strategies for novel vaccine formulations.Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.B epitope multiplicity and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines.Construction and characterization of virus-like particles: a review.Production and evaluation of virus-like particles displaying immunogenic epitopes of porcine reproductive and respiratory syndrome virus (PRRSV)Inclusion of a specific T cell epitope increases the protection conferred against foot-and-mouth disease virus in pigs by a linear peptide containing an immunodominant B cell site.SplitCore Technology Allows Efficient Production of Virus-Like Particles Presenting a Receptor-Contacting Epitope of Human IgE.
P2860
Q26801335-D53BA0A7-ED42-4426-B29B-BC3AA196D632Q30425466-85A15655-8535-4A9E-A31B-154946D07A46Q33830398-A6E8E83F-BC28-4069-AF42-70D65A691E60Q34019891-FB7018AF-FC95-4BED-921F-44C8BCAA9721Q34035499-45729598-237F-4E4B-9BAA-C4D0C8BB5970Q34606356-177FCD5B-2E4D-4761-BFBC-CBE8951541E3Q34608302-36274EA2-8964-4A73-AC1E-9A08E590731EQ34725913-96F9499F-629B-416C-A4EA-36CE29CA986FQ35076683-D516389B-544C-47C4-A9C0-B86023A25D6AQ36034319-36D142F7-B779-4097-9B20-D6D1C7509F8FQ36220629-407F416D-8503-468C-B1A6-BD63DE7F1890Q36470265-7D1975E3-530C-4091-BC93-39E337F36448Q37195521-B6596D4E-7B77-4ACD-AA94-8262B86C3970Q37195802-0965E48B-971A-4970-A852-615D3A1F52DDQ37426707-98929B4B-3D67-489B-83DD-26130F190F26Q38045834-B5572A8D-E579-4FA0-B65A-5B41782C0F23Q38887093-B84BCBE5-7505-432A-9DF5-A22E0AE974B6Q42046690-62381C1C-18C1-4DB1-95CA-EB335EF4DCD8Q42150934-14A94B80-39E7-41E2-AC42-2182265A14BB
P2860
Current strategies for subunit and genetic viral veterinary vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current strategies for subunit and genetic viral veterinary vaccine development.
@en
Current strategies for subunit and genetic viral veterinary vaccine development.
@nl
type
label
Current strategies for subunit and genetic viral veterinary vaccine development.
@en
Current strategies for subunit and genetic viral veterinary vaccine development.
@nl
prefLabel
Current strategies for subunit and genetic viral veterinary vaccine development.
@en
Current strategies for subunit and genetic viral veterinary vaccine development.
@nl
P2093
P50
P1433
P1476
Current strategies for subunit and genetic viral veterinary vaccine development
@en
P2093
Belén Borrego
Daniel Dory
Ghislaine Le Gall-Reculé
José M Escribano
P356
10.1016/J.VIRUSRES.2011.02.006
P577
2011-02-21T00:00:00Z